GlassScriptPhysician profile
Scott M Press
NPI 1609877588
$4,150.57
in general payments reported to CMS, 2019-2025
18 companies · $462 in 2025
The $462 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $408 · 2021: $569 · 2022: $276 · 2023: $1,595 · 2024: $341 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,723 · Travel and Lodging: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.44 |
| Travel and Lodging | $674.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,884.31 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Axonics, INC. | $746.12 | 2020-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $443.32 | 2019-2023 | Myrbetriq |
| Endo Pharmaceuticals INC. | $422.35 | 2019-2024 | Xiaflex, Aveed, Edex |
| Boston Scientific Corporation | $148.22 | 2020-2025 | Bulkamid, Axonics |
| Abbvie INC. | $114.05 | 2019-2022 | |
| Endo USA, INC. | $106.21 | 2024-2025 | Xiaflex, Aveed |
| Neotract INC. | $65.43 | 2019-2020 | |
| Dornier Medtech America, INC | $56.49 | 2019 | |
| Janssen Biotech, INC. | $32.76 | 2021-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $22.45 | 2024 | |
| Sumitomo Pharma America, INC. | $16.84 | 2023 | Gemtesa |
| Teleflex LLC | $16.28 | 2022 | |
| 180 Medical, INC. | $16.05 | 2019 | |
| Hollister Incorporated | $15.66 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.02 | 2019 | |
| Urogen Pharma, INC. | $14.51 | 2024 | |
| Myovant Sciences INC. | $14.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Press listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.